close

Enter

Log in using OpenID

Companion Diagnostics Market

embed
In a recent market study from Transparency Market Research (TMR), the global companion diagnostics market is estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013. This growth amounts to a remarkable CAGR of 18.1% from 20
Transparency Market Research
Need for Higher Drug Efficacy to Drive Global Companion Diagnostics Market to US$5.6 Bn
by 2019
Published Date
Page Report
29-Aug-2013
Request Sample
Buy Now
Press Release
http://www.transparencymarketresearch.com/pressrelease/companion-diagnostics-market.htm
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
[email protected]
Breast Pumps Market
REPORT DESCRIPTION
Companion Diagnostics Market is expected to reach $5.6 billion by 2019, growing
at a compound annual growth rate (CAGR) of 18.1% during the period
In a recent market study from Transparency Market Research (TMR), the global companion diagnostics market is
estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013. This growth amounts to a remarkable
CAGR of 18.1% from 2013 to 2019.The report, titled “Companion Diagnostics Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2013 - 2019”, is available for sale on the company website.Companion diagnostics
enable physicians to make more precise decisions for specific drug treatments depending on the patient’s response at
every stage of the course of treatment. The tests indicate both favorable and adverse reactions to a certain line of treatment
and also help optimize drug dosage.
Companion diagnostics refer to tests or procedures which help physicians in making improved treatment decisions
regarding patients depending on their response to ongoing treatments. The rising demand for personalized medicine has
largely driven the global companion diagnostics market. The market research report offers apt insights on the industry,
tracking its growth, development and success during the forecast period of 2013 to 2019.
The scope and dynamics of the market are covered in the report and the overall industry is segmented on the basis of tests
for various indications and geographical location. Potential growth opportunities, emerging sectors, market drivers,
challenges, landmarks, trends, government regulations and competitive landscape are also highlighted in the research
report.
In addition, the study discusses the value chain as well as Porter’s five forces analysis, highlighting the impact of
suppliers, buyers, substitutes, new entrants and competitors on the global market.
Enquiry before Buying:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387
Overview of the companion diagnostics market
2
Transparency Market Research
Breast Pumps Market
The worldwide market for companion diagnostics was worth $1.8 billion in 2012 and is expected to reach $5.6 billion by
2019, growing at a compound annual growth rate (CAGR) of 18.1% during the period.
The mounting R&D efforts in the field of diagnostics, advances in technologies, increasing focus on targeted therapies,
and the constant attempts on the part of pharmaceutical manufacturers to lower the cost of drugs development has greatly
benefited the industry. Moreover, favorable regularity changes on the part of governments, and the focus of
pharmaceutical companies on in-house development of companion diagnostics or collaborating with diagnostics firms for
the same are expected to further propel the market.
On the other hand, the factors which hamper the growth, as identified by the research report, are unfavorable
reimbursement scenario, lengthy phases of development and approval of diagnostic technologies, and the rising influence
of clinical societies and advocacy groups.
The global companion diagnostics market was led by North America in 2012, contributing more than 35% of the total
revenue share. The major driving forces in the North American regional markets include widening consumer base owing
to rising number of cancer cases, rising awareness regarding personalized healthcare, increased affordability of expensive
procedures, and high-quality medical equipment and technology available. Increasing healthcare infrastructure and greater
acceptance of innovative medical procedures will boost the regional markets in Asia and Latin America.
Browse Full Press Release @
http://www.transparencymarketresearch.com/pressrelease/companion-diagnostics-market.htm
TABLE OF CONTENT
Table of contents
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
3
Transparency Market Research
Breast Pumps Market
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Regulatory changes: The need for development of CDx along with targeted therapies
3.2.2 Increasing demand as well as developmental efforts towards personalized medicine
3.2.3 The pharmacoeconomic advantage: Reduced drug development costs
3.2.4 Increasing cancer incidence worldwide
3.2.5 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Effect of influence of advocacy groups and clinical societies
3.3.2 Prolonged developmental and approval phases
3.3.3 Reimbursement scenario
3.3.4 Impact Analysis of Market Restraints
3.4 Market Opportunity
3.4.1 Expansion into newer indication areas
3.5 Porter’s Five Forces Analysis: Global Companion Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
Chapter 4 Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million)
4.1 Introduction
4.1.1 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %)
4.1.2 Breast Cancer
4
Transparency Market Research
Breast Pumps Market
4.1.2.1 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD
Million)
4.1.3 Lung Cancer
4.1.3.1 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
4.1.4 Colorectal Cancer
4.1.4.1 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD
Million)
4.1.5 Gastric Cancer
4.1.5.1 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD
Million)
4.1.6 Melanoma
4.1.6.1 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
4.1.7 Others (HIV, Thalassemia)
4.1.7.1 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
Chapter 5 Companion Diagnostics Market, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Comparative Analysis: Global Companion Diagnostics Market by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 RoW Companion Diagnostics Market, Size and Forecast 2011 - 2019 (USD Million)
Chapter 6 Competitive Landscape
6.1 Market Share by Key Players, 2012 (%)
Chapter 7 Recommendations
5
Transparency Market Research
Breast Pumps Market
7.1 Adoption of newer business models enabling co-developing companion diagnostics
7.2 Focus on research-intense investments
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.1.5.1 FDA Approval
8.2 Agendia N.V.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Recent Developments
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 BioGenex Laboratories Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Recent Developments
8.5 bioMérieux SA
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
6
Transparency Market Research
Breast Pumps Market
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 GE Healthcare Ltd.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Genomic Health, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Qiagen N.V.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Resonance Health Analysis Services Pty Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Business Strategies
8.10.4 Recent Developments
7
Transparency Market Research
Breast Pumps Market
8.11 Roche Holdings AG
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Siemens Healthcare
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and
consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical,
chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR
research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape,
detailed segmentation, key trends, and strategic recommendations.
Contact
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
8
Transparency Market Research
Author
Priya
Priya45   documents Email
Document
Category
Health and Medicine
Views
10
File Size
455 KB
Tags
diagnostics, Companion Diagnostics Market
1/--pages
Report inappropriate content